Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer-Reference-Cited by-同舟云学术

Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer

Published:2019-07-30 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Bhatt Akshita B.,Gupta Mohit,Hoang Van T.,Chakrabarty Suravi,Wright Thomas D.,Elliot Steven,Chopra Ishveen K.,Monlish Darlene,Anna Katie,Burow Matthew E.,Cavanaugh Jane E.,Flaherty Patrick T.

Funder

National Cancer Institute

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference38 articles.

1. National Breast Cancer Foundation, Breast Cancer Facts2018

2. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer;Anders;Clin Breast Cancer.,2009

3. Treatment of triple negative breast cancer (TNBC): current options and future perspectives;De Laurentiis;Cancer Treat Rev.,2010

4. Triple negative breast cancer: unmet medical needs;Pal;Breast Cancer Res Treat.,2011

5. Tamoxifen resistance in breast cancer;Chang;Biomol Therap.,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diphenylamine;Encyclopedia of Toxicology;2024

2. Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway;BMC Cancer;2023-12-20

3. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs;Biochemical Pharmacology;2021-12

4. Mnt Represses Epithelial Identity To Promote Epithelial-to-Mesenchymal Transition;Molecular and Cellular Biology;2021-10-26

5. MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal;Pancreas;2021-10